Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach ; volume:7 ; number:1 ; day:2 ; month:7 ; year:2012 ; pages:1-18 ; date:12.2012
Molecular neurodegeneration ; 7, Heft 1 (2.7.2012), 1-18, 12.2012
- Creator
-
Proctor, Carole J.
- Contributor
- DOI
-
10.1186/1750-1326-7-32
- URN
-
urn:nbn:de:1111-2016073069190
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T10:58:31+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Proctor, Carole J.
- Pienaar, Ilse Sanet
- Elson, Joanna L.
- Kirkwood, Tom
- SpringerLink (Online service)
Other Objects (12)
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Emotional prosody recognition is impaired in Alzheimer’s disease
The UFMylation pathway is impaired in Alzheimer’s disease
Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Emotional prosody recognition is impaired in Alzheimer’s disease
The UFMylation pathway is impaired in Alzheimer’s disease
Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Emotional prosody recognition is impaired in Alzheimer’s disease
The UFMylation pathway is impaired in Alzheimer’s disease
Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics